HROW
HARROW, INC.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$33.08
−0.15%Forward multiples
Based on analyst estimates
- P/E forward
- 25.70x
- P/E 2026E
- —
- P/E 2027E
- 14.53x
- P/E 2028E
- 8.05x
- P/S forward
- 2.78x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 81.59x
- Price / sales
- 4.50x
- Price / cash flow
- 198.35x
Enterprise value
- Enterprise value
- $1.5B
- EV / sales
- 5.29x
- EV / EBITDA
- 324.92x
- EV / EBIT
- 255.50x
- Market cap
- $1.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026